original ) (raw )Long-Term Outcomes in Belatacept-Treated vs. Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results from BENEFIT-EXT, a Phase III Randomized Study
Maria Rial
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016
View PDFchevron_right
A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)
J. Xing , Josep Grinyo
American Journal of Transplantation, 2010
View PDFchevron_right
Comparable renal graft survival in African-American and Caucasian recipients
Robert Wyatt
Pediatric Nephrology, 1998
View PDFchevron_right
Equivalent outcomes with primary and retransplantation in African-American deceased-donor renal allograft recipients
Atul Singh
Surgery, 2009
View PDFchevron_right
Similar Outcomes among Black and White Renal Allograft Recipients
Douglas Schaubel
Journal of the American Society of Nephrology, 2009
View PDFchevron_right
Relative impact of donor type on renal allograft survival in black and white recipients
Friedrich Port
American Journal of Kidney Diseases, 1995
View PDFchevron_right
Long-Term Improvement of Deceased Donor Renal Allograft Survival Since 1996: A Single Transplant Center Study
Jose Ramos
Transplantation, 2010
View PDFchevron_right
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
Ramin Sam
New England Journal of Medicine, 2000
View PDFchevron_right
The long-term outcome of renal transplantation. A 10-year follow-up of 765 recipients
Andrzej Górski
Polish Archives of Internal Medicine
View PDFchevron_right
Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients
philippe lang
Transplant International, 2002
View PDFchevron_right
Late graft failure and death in renal transplant recipients: Analysis in a single-center population of 1500 patients
Christian Hiesse
Transplantation Proceedings, 1997
View PDFchevron_right
Does donor race still make a difference in deceased-donor African-American renal allograft recipients?
Atul Singh
The American Journal of Surgery, 2010
View PDFchevron_right
Optimizing the use of cyclosporine (neoral) for recipients of living donor kidneys
Todd Brennan
Transplantation Proceedings, 2004
View PDFchevron_right
Outcome of Cadaveric Renal Transplant Patients Treated for 10 Years with Cyclosporine
Maite Rivera Gorrin
Transplantation, 2001
View PDFchevron_right
Survival of living-related kidney graft recipients in the era of modern immunosuppressive treatment
Enver Zerem
Annals of Saudi Medicine, 2011
View PDFchevron_right
The Effect of Donor Age and Immunosuppression Protocol in Kidney Transplantation
Ibrahim Berber
Transplantation Journal, 2004
View PDFchevron_right
Can We Prevent Chronic Graft Loss? Strategies and Outcome in 1000 Live Related Renal Transplants from a Developing Country
Mirza Zafar
Transplantation Journal, 2004
View PDFchevron_right
Inferior outcome of two-haplotype matched renal transplants in blacks: Role of early rejection
Friedrich Port
Kidney International, 1995
View PDFchevron_right
Risk Factors Associated With Graft Loss and Patient Survival After Kidney Transplantation
Claudia Felipe
Transplantation Proceedings, 2009
View PDFchevron_right
Impact of age, gender and race on patient and graft survival following renal transplantation – developing country experience
Rafique Moosa
South African Medical Journal, 2004
View PDFchevron_right
Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study
Josep Grinyo
Transplant International, 2012
View PDFchevron_right
Cyclosporine Versus Tacrolimus in Immunosuppressive Maintenance Regimens in Renal Transplants in Brazil: Survival Analysis from 2000 to 2004
Mariângela Cherchiglia
Annals of Pharmacotherapy, 2010
View PDFchevron_right
Racial differences in renal allograft survival: The role of systemic hypertension
luis reynaldo Ortiz
Kidney International, 1995
View PDFchevron_right
Ten-year survival of second kidney transplants: Impact of immunologic factors and renal function at 12 months
Pascal Daguin , Diego Cantarovich
Kidney International, 2003
View PDFchevron_right
Ten-year kidney transplant survival of cyclosporine- or tacrolimus-treated patients in Brazil
Mariângela Cherchiglia
Expert Review of Clinical Pharmacology, 2016
View PDFchevron_right
Factors Affecting Graft Survival among Patients Receiving Kidneys from Live Donors: A Single-Center Experience
Ayman Refaie
BioMed Research International, 2013
View PDFchevron_right
Long-term survival in renal transplant recipients with graft function
Akinlolu Ojo
Kidney International, 2000
View PDFchevron_right
Long Term Outcomes of Kidney Transplant: Characteristics of Recipients with 20 or More Years of Graft Survival
stefano faenza
Journal of Medical & Surgical Pathology, 2016
View PDFchevron_right
Effect of the Use or Nonuse of Long-Term Dialysis on the Subsequent Survival of Renal Transplants from Living Donors
Kevin Mange
New England Journal of Medicine, 2001
View PDFchevron_right
Deceased-donor kidney transplantation: improvement in long-term survival
Marina Marin
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011
View PDFchevron_right